Comparison of the matrix synthesizing abilities of human adipose-derived stromal vascular fraction cells and fibroblasts

Soo Hye Shin, Tae Kyoung Yun, Seung-Kyu Han, Seong-Ho Jeong, Eun-Sang Dhong, Woo-Kyung Kim

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

For facial soft tissue augmentation or wound coverage using tissue-engineering technology, cultured fibroblasts have been most commonly used as key cells and their properties have been extensively studied. Clinical strategies based on human cultured fibroblasts, however, require Food and Drug Administration (FDA) approval for the facilities and the procedures used and time-consuming culture. Adipose tissue-derived stromal vascular fraction (SVF) cells may be a reliable alternative to fibroblasts because they are easily harvested by liposuction and do not require culture or FDA approval. No quantitative standard governing their use has, however, been issued. The purpose of this study was to quantitatively compare matrix-forming abilities of SVF cells and fibroblasts. Human dermal fibroblasts were obtained from the dermis of 10 healthy adults and cultured, and SVF cells were obtained from 10 patients who underwent liposuction. Monolayer and suspension cell cultures were performed using both cell types for 3 days. Cell proliferations, collagen synthesis levels, and glycosaminoglycan levels were compared using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay, a collagen type I carboxyterminal propeptide enzyme immunoassay, and the Blyscan Dye method, respectively. Cell proliferation ratios (fibroblasts versus SVF cells) in monolayer and suspension cultures were 1:0.75 and 1:0.99, respectively; collagen synthesis ratios in monolayer and suspension cultures were 1:0.50 and 1:0.52, respectively; and glycosaminoglycan production ratios were 1:0.70 and 1:0.74, respectively. The results of this in vitro study indicate that SVF cells have 50-74% of the matrix-forming ability of fibroblasts.

Original languageEnglish
Pages (from-to)1246-1250
Number of pages5
JournalJournal of Craniofacial Surgery
Volume26
Issue number4
DOIs
Publication statusPublished - 2015 Jun 1

Fingerprint

Blood Vessels
Fibroblasts
Drug Approval
Lipectomy
Suspensions
United States Food and Drug Administration
Glycosaminoglycans
Collagen
Cell Proliferation
Tissue Engineering
Dermis
Collagen Type I
Immunoenzyme Techniques
Adipose Tissue
Coloring Agents
Cell Culture Techniques
Technology
Skin
Wounds and Injuries

Keywords

  • Fibroblast
  • Stromal vascular fraction cell
  • Tissue engineering

ASJC Scopus subject areas

  • Surgery
  • Otorhinolaryngology

Cite this

Comparison of the matrix synthesizing abilities of human adipose-derived stromal vascular fraction cells and fibroblasts. / Shin, Soo Hye; Yun, Tae Kyoung; Han, Seung-Kyu; Jeong, Seong-Ho; Dhong, Eun-Sang; Kim, Woo-Kyung.

In: Journal of Craniofacial Surgery, Vol. 26, No. 4, 01.06.2015, p. 1246-1250.

Research output: Contribution to journalArticle

@article{48bf4399a84d4eac9b53636c924b4460,
title = "Comparison of the matrix synthesizing abilities of human adipose-derived stromal vascular fraction cells and fibroblasts",
abstract = "For facial soft tissue augmentation or wound coverage using tissue-engineering technology, cultured fibroblasts have been most commonly used as key cells and their properties have been extensively studied. Clinical strategies based on human cultured fibroblasts, however, require Food and Drug Administration (FDA) approval for the facilities and the procedures used and time-consuming culture. Adipose tissue-derived stromal vascular fraction (SVF) cells may be a reliable alternative to fibroblasts because they are easily harvested by liposuction and do not require culture or FDA approval. No quantitative standard governing their use has, however, been issued. The purpose of this study was to quantitatively compare matrix-forming abilities of SVF cells and fibroblasts. Human dermal fibroblasts were obtained from the dermis of 10 healthy adults and cultured, and SVF cells were obtained from 10 patients who underwent liposuction. Monolayer and suspension cell cultures were performed using both cell types for 3 days. Cell proliferations, collagen synthesis levels, and glycosaminoglycan levels were compared using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay, a collagen type I carboxyterminal propeptide enzyme immunoassay, and the Blyscan Dye method, respectively. Cell proliferation ratios (fibroblasts versus SVF cells) in monolayer and suspension cultures were 1:0.75 and 1:0.99, respectively; collagen synthesis ratios in monolayer and suspension cultures were 1:0.50 and 1:0.52, respectively; and glycosaminoglycan production ratios were 1:0.70 and 1:0.74, respectively. The results of this in vitro study indicate that SVF cells have 50-74{\%} of the matrix-forming ability of fibroblasts.",
keywords = "Fibroblast, Stromal vascular fraction cell, Tissue engineering",
author = "Shin, {Soo Hye} and Yun, {Tae Kyoung} and Seung-Kyu Han and Seong-Ho Jeong and Eun-Sang Dhong and Woo-Kyung Kim",
year = "2015",
month = "6",
day = "1",
doi = "10.1097/SCS.0000000000001828",
language = "English",
volume = "26",
pages = "1246--1250",
journal = "Journal of Craniofacial Surgery",
issn = "1049-2275",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Comparison of the matrix synthesizing abilities of human adipose-derived stromal vascular fraction cells and fibroblasts

AU - Shin, Soo Hye

AU - Yun, Tae Kyoung

AU - Han, Seung-Kyu

AU - Jeong, Seong-Ho

AU - Dhong, Eun-Sang

AU - Kim, Woo-Kyung

PY - 2015/6/1

Y1 - 2015/6/1

N2 - For facial soft tissue augmentation or wound coverage using tissue-engineering technology, cultured fibroblasts have been most commonly used as key cells and their properties have been extensively studied. Clinical strategies based on human cultured fibroblasts, however, require Food and Drug Administration (FDA) approval for the facilities and the procedures used and time-consuming culture. Adipose tissue-derived stromal vascular fraction (SVF) cells may be a reliable alternative to fibroblasts because they are easily harvested by liposuction and do not require culture or FDA approval. No quantitative standard governing their use has, however, been issued. The purpose of this study was to quantitatively compare matrix-forming abilities of SVF cells and fibroblasts. Human dermal fibroblasts were obtained from the dermis of 10 healthy adults and cultured, and SVF cells were obtained from 10 patients who underwent liposuction. Monolayer and suspension cell cultures were performed using both cell types for 3 days. Cell proliferations, collagen synthesis levels, and glycosaminoglycan levels were compared using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay, a collagen type I carboxyterminal propeptide enzyme immunoassay, and the Blyscan Dye method, respectively. Cell proliferation ratios (fibroblasts versus SVF cells) in monolayer and suspension cultures were 1:0.75 and 1:0.99, respectively; collagen synthesis ratios in monolayer and suspension cultures were 1:0.50 and 1:0.52, respectively; and glycosaminoglycan production ratios were 1:0.70 and 1:0.74, respectively. The results of this in vitro study indicate that SVF cells have 50-74% of the matrix-forming ability of fibroblasts.

AB - For facial soft tissue augmentation or wound coverage using tissue-engineering technology, cultured fibroblasts have been most commonly used as key cells and their properties have been extensively studied. Clinical strategies based on human cultured fibroblasts, however, require Food and Drug Administration (FDA) approval for the facilities and the procedures used and time-consuming culture. Adipose tissue-derived stromal vascular fraction (SVF) cells may be a reliable alternative to fibroblasts because they are easily harvested by liposuction and do not require culture or FDA approval. No quantitative standard governing their use has, however, been issued. The purpose of this study was to quantitatively compare matrix-forming abilities of SVF cells and fibroblasts. Human dermal fibroblasts were obtained from the dermis of 10 healthy adults and cultured, and SVF cells were obtained from 10 patients who underwent liposuction. Monolayer and suspension cell cultures were performed using both cell types for 3 days. Cell proliferations, collagen synthesis levels, and glycosaminoglycan levels were compared using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay, a collagen type I carboxyterminal propeptide enzyme immunoassay, and the Blyscan Dye method, respectively. Cell proliferation ratios (fibroblasts versus SVF cells) in monolayer and suspension cultures were 1:0.75 and 1:0.99, respectively; collagen synthesis ratios in monolayer and suspension cultures were 1:0.50 and 1:0.52, respectively; and glycosaminoglycan production ratios were 1:0.70 and 1:0.74, respectively. The results of this in vitro study indicate that SVF cells have 50-74% of the matrix-forming ability of fibroblasts.

KW - Fibroblast

KW - Stromal vascular fraction cell

KW - Tissue engineering

UR - http://www.scopus.com/inward/record.url?scp=84986607488&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84986607488&partnerID=8YFLogxK

U2 - 10.1097/SCS.0000000000001828

DO - 10.1097/SCS.0000000000001828

M3 - Article

C2 - 26080167

AN - SCOPUS:84986607488

VL - 26

SP - 1246

EP - 1250

JO - Journal of Craniofacial Surgery

JF - Journal of Craniofacial Surgery

SN - 1049-2275

IS - 4

ER -